Previous studies have found that the overexpression of cathepsin B leads to the invasiveness and metastasis of breast cancer, pancreatic cancer, HCC, and colorectal cancer, by activating the ErbB oncogenic signaling pathway11–14. This evidence concerns the gene CTSB and hepatocellular carcinoma.